Pfizer pares outlook as net falls
By Peter Loftus —Josée Rose contributed to this article.
The Wall Street Journal Europe
23 Apr 2007

Pfizer Inc.’s first- quarter profit dropped 18% on restructuring-and-acquisition costs, while revenue rose 6.2% on stronger sales of cholesterol drug Lipitor and treatments for cancer and smoking cessation. The world’s largest drug maker by sales also... read more...

Tech Tags: The Wall Street Journal Europe newspaper Corporate News

---

Chinese drug makers feel pain of government overhauls, probe
By Nicholas Zamiska and Jason Leow
The Wall Street Journal Asia
18 Apr 2007

FOR INVESTORS, the Chinese pharmaceuticals sector is as fraught with risk as it is full of promise. For now, the best investment prescription may be caution. A spate of Chinese drug companies have listed shares in Hong Kong and New York this year, and... read more...

Tech Tags: The Wall Street Journal Asia newspaper Asian Markets Lineup

Consumer watchdog to investigate changes in distribution of medicines

Consumer watchdog to investigate changes in distribution of medicines

Marianne Barriaux

The Guardian

05 Apr 2007



Pharmacists and drug wholesalers yesterday welcomed the decision by the Office of Fair Trading to investigate the distribution of medicines in the UK. The OFT’s move followed the implementation of a new supply arrangement between Pfizer and UniChem,... read more...

Tech Tags: The Guardian newspaper Financial